Stockreport

Karyopharm Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations
PDF – Achieved Second Quarter 2022 Total Revenue of $39.7 Million, Up 76% Versus Second Quarter 2021;XPOVIO® (selinexor) Net Product Revenue of $29.0 Million, a 44% Increase [Read more]